ARCHIVES

Senate Approves 15% Increase For NIH; House Passes 5.6% Raise, But Favors More.

This article is from The Cancer Letter archive.

Vol. 26 No. 27 | July 7, 2000

Download PDF Visit The Full Archive

Related Articles

FDA Approves Xeloda For Colon Cancer; Phase III Data Not Reviewed By ODAC.

May 4, 2001

CIDAC Bids Not Limited To Cancer Research Centers

January 17, 1975

ODAC Recommends Ethyol, DaunoXome For FDA Approval

June 16, 1995

Scientists Falsified Research, ORI Says

July 5, 1996

Breast Cancer Coalition Seeks Continued DOD Funding For Research

July 2, 1993

FDA Invites Ad Hoc Consumer Reps To ODAC Meetings

February 17, 1995